50 years of Progress Against Cancer
March 15, 2012 - March 16, 2012
Venue: Brussels, Belgium
We invite you to view the presentations delivered at the EORTC 50th Anniversary Conference.
Webcasts courtesy of The Informed Scientist.
Session 1: A 50-year history of cancer clinical research
Chairs: S. Garattini & F. Meunier
Message from HRH Princess Astrid of Belgium
HRH Princess Astrid of Belgium
The challenges of the EORTC after half a century
Jean-Yves Blay
EORTC Charitable Trust : The challenges of funding academic research
Christopher Mallaby
Patient voice: The vision for the 21st century
Peter Kapitein
Session 2: A Pan-European collaboration
Chairs: D. Van Bekkum & G. McVie
The European Commission vision for Pan-European academic clinical research
Ruxandra Draghia-Akli
European Cooperation: Dream – Reality – Necessity
Françoise Meunier
Henri Tagnon lecture: The changing paradigms for melanoma care and research
Alexander Eggermont
Session 3: Achievements and trials that changed medical practice
Chairs: U. Veronesi & L. Denis
Research in surgical oncology: Lessons from the past and less is more
Emiel Rutgers
From radiation-therapy to radiation-oncology: A 50-year EORTC contribution
Jean-Claude Horiot
Clinical research in medical oncology: The patient, the tumor, the target and the drug
Patrick Schöffski
Progress in Haematology:
Chairs: JC. Horiot & J. Jassem
Adult Leukemia
Jean-Pierre Marie
Children Leukemia
Yves Benoit
Lymphoma
Michel Henry-Amar
50 years of management of febrile neutropenia
Peter Donnelly
EORTC research in quality of life
Galina Velikova
Session 4: Integrating biology in novel clinical trials
Chairs: N. Harbeck & A. van Oosterom
IMI and cancer research
Michel Goldman
Translational research in brain tumors
Monika Hegi
The need for new concepts in clinical trials: The role of NOCI & the MINDACT example
Martine Piccart
Adapting the EORTC Headquarters to the rapidly changing environment
Denis Lacombe
Session 5: Future challenges and perspectives
Chairs: M. Piccart & A. Eggermont
The economics of innovative cancer treatments and policy implications
Koen Torfs
Functional Imaging as a surrogate endpoint for clinical efficacy
Lalitha Shankar
Methodology, response to treatment and RECIST
Jan Bogaerts
Prerequisites for making translational research an essential component of EORTC trials
Nadia Harbeck
The path forward
Roger Stupp
Next events
EORTC Imaging Group Spring Meeting
April 19
Brussels, Belgium (hybrid)
EORTC Pathobiology Group Spring Meeting
April 24
Virtual Event
EORTC Head and Neck Cancer Group Spring Meeting
April 26 - April 27
Hamburg, DE
ESTRO 2024
May 3 - May 7
Glasgow
EORTC Lung Cancer Group Spring Meeting
May 16 - May 18
Malaga, Spain
